Sponsor pipeline

Xiaojun Chen clinical trial pipeline

Get alerts when Xiaojun Chen's trials change

5 active trials 3 recruiting 4 Phase 3 2 disease areas 4 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-16

What changed in the last 30 days

2026-09-11
Primary completion pushed: 2026-03-30 → 2028-03-30
Completion pushed: 2027-03-30 → 2028-03-30
NCT06379113 GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients · Phase 2/3
2026-09-11
Primary completion pushed: 2026-03-30 → 2028-03-30
Completion pushed: 2027-03-30 → 2028-03-30
NCT05316935 GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical… · Phase 2/3

Active trials by phase

Phase 2/3
4
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2/3
NCT05316935 GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical… Endometrial Neoplasms Recruiting 2026-09-10
NCT06379113 GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients Endometrial Neoplasms Recruiting 2026-09-10
NCT05316493 Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia Atypical Endometrial Hyperplasia Recruiting 2026-06-04
NCT06390904 GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients Atypical Endometrial Hyperplasia Active, Not Recruiting 2025-08-11
Not applicable
NCT04276532 Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer… Middle-high Risk Endometrial Cancer Active, Not Recruiting 2026-05-12

Disease areas by active trials

Endometrial Cancer (3) · Obesity (3)

Get alerts when Xiaojun Chen's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free